Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Invested Capital (2016 - 2026)

Nutex Health (NUTX) has disclosed Invested Capital for 17 consecutive years, with $458.8 million as the latest value for Q1 2026.

  • For Q1 2026, Invested Capital rose 76.48% year-over-year to $458.8 million; the TTM value through Mar 2026 reached $458.8 million, up 76.48%, while the annual FY2025 figure was $656.2 million, 239.93% up from the prior year.
  • Invested Capital hit $458.8 million in Q1 2026 for Nutex Health, down from $656.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $656.2 million in Q4 2025 and bottomed at $82.7 million in Q4 2023.
  • Average Invested Capital over 5 years is $244.1 million, with a median of $158.7 million recorded in 2022.
  • Year-over-year, Invested Capital crashed 78.22% in 2023 and then skyrocketed 426.69% in 2025.
  • Nutex Health's Invested Capital stood at $158.7 million in 2022, then crashed by 47.87% to $82.7 million in 2023, then skyrocketed by 133.4% to $193.0 million in 2024, then skyrocketed by 239.93% to $656.2 million in 2025, then tumbled by 30.08% to $458.8 million in 2026.
  • According to Business Quant data, Invested Capital over the past three periods came in at $458.8 million, $656.2 million, and $442.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.